Literature DB >> 21527414

Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with Stevens-Johnson syndrome.

Ana Estela B P P Sant' Anna1, Rossen M Hazarbassanov, Denise de Freitas, José Álvaro P Gomes.   

Abstract

OBJECTIVE: To evaluate minor salivary glands and labial mucous membrane graft in patients with severe symblepharon and dry eye secondary to Stevens-Johnson syndrome (SJS).
METHODS: A prospective, non-comparative, interventional case series of 19 patients with severe symblepharon and dry eye secondary to SJS who underwent labial mucous membrane and minor salivary glands transplantation. A complete ophthalmic examination including the Schirmer I test was performed prior to and following surgery. All patients had a preoperative Schirmer I test value of zero.
RESULTS: Nineteen patients with severe symblepharon and dry eye secondary to SJS were included in the study. There was a statistically significant improvement in the best spectacle-corrected visual acuity in eight patients (t test; p=0.0070). Values obtained in the Schirmer I test improved significantly in 14 eyes (73.7%) 6 months following surgery (χ(2) test; p=0.0094). A statistically significant increase in tear production (Schirmer I test) was found in eyes that received more than 10 glands per graft compared with eyes that received fewer glands (χ(2) test; p=0.0096). Corneal transparency improved significantly in 11 (72.2%) eyes and corneal neovascularisation improved significantly in five eyes (29.4%) (McNemar test; p=0.001 and p=0.0005). The symptoms questionnaire revealed improvement in foreign body sensation in 53.6% of the patients, in photophobia in 50.2% and in pain in 54.8% (Kruskal-Wallis test; p=0.0167).
CONCLUSION: Labial mucous membrane and minor salivary glands transplantation were found to constitute a good option for the treatment of severe symblepharon and dry eye secondary to SJS. This may be considered as a step prior to limbal stem cell and corneal transplantation in these patients.

Entities:  

Mesh:

Year:  2011        PMID: 21527414     DOI: 10.1136/bjo.2010.199901

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

Review 1.  [Conjunctival reconstruction-State of the art of regenerative treatment forms beyond the limbus].

Authors:  Kristina Spaniol; Maria Borrelli; Johannes Menzel-Severing; Gerd Geerling
Journal:  Ophthalmologie       Date:  2022-06-14

2.  Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Seema Kamala Muralidharan; Sumathi Arumugam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-29       Impact factor: 3.117

Review 3.  Molecular mechanisms and treatments for ocular symblephara.

Authors:  Aditi Swarup; Christopher N Ta; Albert Y Wu
Journal:  Surv Ophthalmol       Date:  2021-04-29       Impact factor: 6.048

4.  Use of saliva flow rate measurement in minor salivary glands autotransplantation for treatment of severe dry eye disease.

Authors:  Jia-Zeng Su; Zhen Wang; Xiao-Jing Liu; Lan Lv; Guang-Yan Yu
Journal:  Br J Ophthalmol       Date:  2021-03-05       Impact factor: 5.908

5.  Reversed skin graft combining with lip mucosa transplantation in treating recurrent severe symblepharon: A case report.

Authors:  Tian Li; Ying Shao; Quan Lin; Duo Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

6.  Long-term follow up of oral mucosa autograft sutured to the sclera in severe symblepharon.

Authors:  Hernan Martinez-Osorio; Silvana Artioli Schellini; Luz Stella Marin-Muñoz
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-25

Review 7.  Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in Brazil.

Authors:  Tais Hitomi Wakamatsu; Myrna Serapião Dos Santos; Telma Pereira Barreiro; Ana Estela Besteti Pires Ponce Sant'Anna; Fabíola Murta; Alexandre Xavier da Costa; Leonardo Guedes C Marculino; Rafael Jorge Alves de Alcântara; Charles Costa de Farias; José Álvaro Pereira Gomes
Journal:  Front Med (Lausanne)       Date:  2021-06-18

8.  Bioengineered Lacrimal Gland Organ Regeneration in Vivo.

Authors:  Masatoshi Hirayama; Kazuo Tsubota; Takashi Tsuji
Journal:  J Funct Biomater       Date:  2015-07-30

9.  Functional lacrimal gland regeneration by transplantation of a bioengineered organ germ.

Authors:  Masatoshi Hirayama; Miho Ogawa; Masamitsu Oshima; Yurie Sekine; Kentaro Ishida; Kentaro Yamashita; Kazutaka Ikeda; Shigeto Shimmura; Tetsuya Kawakita; Kazuo Tsubota; Takashi Tsuji
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Assessing full thickness oral mucosal grafting: complications and postoperative outcomes in a broad collective of patients.

Authors:  Daniel Pilger; Christoph von Sonnleithner; Eckart Bertelmann
Journal:  BMJ Open Ophthalmol       Date:  2020-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.